Stroke is a fourth leading cause of death and a major cause of long-term disability, which inflicts substantial economic and societal burdens. Drug therapies aimed at post-stroke recovery that can enhance endogenous neurogenesis may help minimize the cost related to prolonged hospital stays and rehabilitation. Ginkgo biloba, a widely studied herbal product for the treatment of neurological disorders, offers endogenous neurogenesis-enhancing properties that hold the promise of providing recovery-improving benefits to stroke patients.
↧